Utilizing Exosomes for a Comprehensive Strategy in Managing Dry Eye Disease - Takeaways - MDSpire

Utilizing Exosomes for a Comprehensive Strategy in Managing Dry Eye Disease

  • By

  • Jiaping Song

  • Xinyan Yi

  • Zhongliang Geng

  • Jun Tian

  • Tingting Wang

  • Xiaohai Song

  • Shaokang Ma

  • Hongwei Li

  • Yongcheng Xu

  • March 11, 2026

  • 0 min

Share

  • 1

    Dry eye disease (DED) is a chronic disorder characterized by unstable tear film and ocular surface inflammation, affecting 5% to 50% of the global population.

  • 2

    Exosomes are extracellular vesicles that facilitate intercellular communication and have potential as therapeutic agents, drug delivery vehicles, and disease biomarkers.

  • 3

    The review proposes a 'Triple Threat Approach' for exosomes, integrating their roles in therapy, drug delivery, and diagnostics for managing DED.

  • 4

    Exosomes can deliver therapeutic molecules to ocular tissues, improving treatment efficacy and enabling non-invasive diagnosis and prognosis of DED.

  • 5

    Current challenges in clinical translation of exosome-based strategies highlight the need for further research to advance cell-free therapies in ophthalmology.

Original Source(s)

Utilizing Exosomes for a Comprehensive Strategy in Managing Dry Eye Disease

  • by Jiaping Song, Xinyan Yi, Zhongliang Geng, Jun Tian, Tingting Wang, Xiaohai Song, Shaokang Ma, Hongwei Li, Yongcheng Xu

  • March 11, 2026

Related Content

Equal Pay in Ophthalmology? Not Yet

A decade of AAMC salary data reveals a persistent gender pay gap in academic ophthalmology—and projects it will never close at senior ranks

Transcriptomic Analysis of Lacrimal Glands in a Sjogren’s Disease Animal Model Reveals Key Molecular Factors and Altered Biological Processes Associated with Glandular Inflammation and Dysfunction

Ocular Surface Optimization: The Best First Step in Modern Cataract Surgery

Why a healthy preoperative ocular surface is no longer optional